Lawrence Helson
Plus aucun poste en cours
Provenance du réseau au premier degré de Lawrence Helson
Entité | Type d'entité | Industrie | |
---|---|---|---|
New York Medical College
17
| College/University | Other Consumer Services | 17 |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY.
9
| Non-Profit Organization | Hospital/Nursing Management | 9 |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines.
2
| Subsidiary | Biotechnology | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Lawrence Helson via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Director/Board Member | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member | |
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Investment Managers | Founder | |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
iCeutica, Inc.
iCeutica, Inc. Pharmaceuticals: MajorHealth Technology iCeutica, Inc. manufactures pharmaceutical products. It offers SoluMatrix platform, a drug reformulation and delivery technology for poorly water-soluble compounds. This technology enables iCeutica to make significantly improved formulations of approved and development stage drugs, some of which have been shown in late stage clinical trials to work faster, at a lower dose or be delivered to the body by an alternative route. The company was founded by James Williams and Matthew Callahan in 2005 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Pharmaceuticals: Major | Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal | |
University of Glasgow | College/University | Undergraduate Degree Doctorate Degree | |
HBM HEALTHCARE INVESTMENTS AG | Investment Managers | Founder | |
New York University | College/University | Corporate Officer/Principal Undergraduate Degree | |
Ocimum Bio Solutions (India) Ltd.
Ocimum Bio Solutions (India) Ltd. Medical/Nursing ServicesHealth Services Ocimum Bio Solutions (India) Ltd. operates as a genomics company which provides laboratory practice-compliant microarray services. It serves biopharmaceutical, diagnostics, agriculture, food and nutrition sectors. The firm provides biorepository and genomic services support for the genetic alliances. The company was founded by Pammi Sujata, Anuradha Acharya and Venkata Subash Lingareddy in 2000 and is headquartered in Hyderabad, India. | Medical/Nursing Services | Director/Board Member | |
The State University of New York | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
TeGenero AG
TeGenero AG Pharmaceuticals: MajorHealth Technology TeGenero AG discovers and develops novel therapeutics. It is a biopharmaceutical company providing services in the identification and development of effective and applicable therapeutics for the treatment of severe immunological disorders. It's first development candidate TGN1412, a SuperMAB with specificity for the T cell surface receptor CD28 is in non-clinical development. Clinical applications of SuperMAB and its derived compounds are expected to solve unmet medical needs in the fields of cancer-related immunodeficiencies such as B-cell chronic lymphocytic leukaemia and autoimmune/inflammatory diseases like rheumatoid arthritis. The company was founded in 2000 and is headquartered in Wurzburg, Germany. | Pharmaceuticals: Major | Chairman | |
Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Undergraduate Degree | |
University of Regensburg | College/University | Undergraduate Degree | |
American Association for the Advancement of Science
American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
New York Academy of Sciences
New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
VIVORYON THERAPEUTICS N.V. | Biotechnology | Chairman | |
HealthEdge Investment Partners, LLC
HealthEdge Investment Partners, LLC Investment ManagersFinance HealthEdge Investment Partners, LLC (HealthEdge Investment Partners) is a private equity firm founded in 2005 by Harold S. Blue and Phillip Dingle. The firm is headquartered in Tampa, Florida. | Investment Managers | Consultant / Advisor | |
Weill Cornell Medical College | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
credentis ag
credentis ag Medical SpecialtiesHealth Technology credentis ag designs, develops, manufactures, and markets dental devices. The firm offers CURODONT. The company was founded by Dominik A. Lysek in January 2010 and is headquartered in Windisch, Switzerland. | Medical Specialties | Chairman | |
Druid BioVentures LLC
Druid BioVentures LLC Financial ConglomeratesFinance Druid BioVentures LLC operates as an investment firm. It specializes in investments in novel drug with a focus on virtual companies. The company is headquartered in Philadelphia, PA. | Financial Conglomerates | Corporate Officer/Principal | |
StartAngels Network
StartAngels Network Packaged SoftwareTechnology Services StartAngels Network operates as a platform for business angel investors. Its angle investors invest directly in the start-up companies, coach them, and provide useful contacts. The company was founded by Peter H. Müller in 2000 and is headquartered in Zurich, Switzerland. | Packaged Software | Director/Board Member | |
Reha-Stim Medtec AG
Reha-Stim Medtec AG Medical SpecialtiesHealth Technology YouRehab AG creates interactive therapy systems for neurological motor disorders. It offers YouGrabber, an all-in-one upper limb rehabilitation product for arms and fingers, which trains patients at peak intensity using rehabilitation gaming to enahcne clinical outcomes; YouKicker, a lower limb rehabilitation product for legs and feet. The company was founded by Oliver Ullmann, Kynan Eng, Edith Chevrier, Lisa Holper, Daniel Kiper, Pawal Pyk and Ewa Siekierka in April 2010 and is headquartered in Schlieren, Switzerland. | Medical Specialties | Director/Board Member | |
Advanced Osteotomy Tools - AOT AG
Advanced Osteotomy Tools - AOT AG Medical SpecialtiesHealth Technology Advanced Osteotomy Tools-AOT AG develops, manufactures, and markets medical devices and tools for bone-cutting. Its device combines three-dimensional (3D) pre-operative planning and a navigation system with a miniaturized laser mounted on a robotic arm. The company was founded by Alfredo E. Bruno, Philippe Cattin, Philipp Jürgens, and Hans-Florian Zeilhofer in 2011 and is headquartered in Allschwil, Switzerland. | Medical Specialties | Chairman | |
Platzerinvest AG | Director/Board Member | ||
Platzer Consult GmbH | Chief Executive Officer | ||
Leman Micro Devices SA
Leman Micro Devices SA SemiconductorsElectronic Technology Leman Micro Devices SA engages in the development of sensor and software systems that measures blood pressure, body temperature, blood oxygen saturation, heart rate and respiration rate in smartphone. The company was founded by Chris Elliott and Mark-Eric Jones in 2010 and is headquartered in Lausanne, Switzerland. | Semiconductors | Chairman | |
Gerstner Sloan Kettering Graduate School of Biomedical Science | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Bio-Bac, Inc.
Bio-Bac, Inc. Chemicals: SpecialtyProcess Industries Bio-Bac, Inc. specializes in biological treatment of organic waste through a bacterial bioaugmentation process. Its solutions include wastewater treatment, nitrification – ammonia degradation, ponds and water gardens, golf, hydrocarbons, household and commercial and agricultural treatment. The company is headquartered in Sherbrooke, Canada. | Chemicals: Specialty | Director/Board Member | |
Peripal AG
Peripal AG Medical SpecialtiesHealth Technology Peripal AG engages in the development and commercialization of aid for the dialysis. It offers PeriSafe a novel patient assist device for the safe and easy connection in Peritoneal Dialysis. The company was founded by Sandra Neumann in 2015 and is headquartered in Zurich, Switzerland. | Medical Specialties | Director/Board Member | |
ARIX BIOSCIENCE PLC | Investment Managers | Director/Board Member | |
BC Platforms AG
BC Platforms AG Data Processing ServicesTechnology Services BC Platforms AG provides powerful genomic data management and analysis solutions. It offers pharmaceutical, biobank, healthcare and academia products. The company was founded by Timo Kanninen in 1997 and is headquartered in Basel, Switzerland. | Data Processing Services | Director/Board Member | |
Sloan-Kettering Institute for Cancer Research | Corporate Officer/Principal Corporate Officer/Principal |
Statistiques
Internationale
Etats-Unis | 26 |
Suisse | 12 |
Allemagne | 9 |
Canada | 3 |
Royaume-Uni | 3 |
Sectorielle
Health Technology | 19 |
Consumer Services | 10 |
Finance | 8 |
Commercial Services | 7 |
Process Industries | 3 |
Opérationnelle
Director/Board Member | 126 |
Corporate Officer/Principal | 93 |
Chairman | 34 |
Founder | 23 |
Doctorate Degree | 22 |
Relations les plus connectées
Insiders | |
---|---|
David C. U'Prichard | 49 |
James Robinson | 42 |
Erich Maximilian Platzer | 31 |
Alfred E. Smith | 22 |
David Scheinberg | 17 |
John Gunn | 13 |
Alan Tuchman | 13 |
Murray Brennan | 12 |
Antony Pfaffle | 11 |
Brendan P. Rae | 11 |
Raj Kumar Tiwari | 11 |
John Mendelsohn | 10 |
Jan Geliebter | 9 |
Steven Schwarz | 8 |
Pierre Vandepapeliere | 8 |
- Bourse
- Insiders
- Lawrence Helson
- Connexions Sociétés